Target intelligence / Profile preview

Calcium modulating ligand (CAMLG)

Target
CAMLG
Molecular classification
Signaling protein, integral membrane protein, TNF receptor ligand
01

Overview

Calcium modulating ligand (CAMLG) is an integral membrane signaling protein required for the stability of GET1 and essential for proper calcium signaling, especially in T and B lymphocytes. It acts downstream of the T cell receptor (TCR) and upstream of calcineurin by binding to cyclophilin B and causing calcium influx. This protein is implicated in immune cell activation and survival, and it has documented roles in both normal immune function and disease processes where calcium signaling is disrupted (e.g., certain cancers, congenital disorders of glycosylation). CAMLG is recognized as a ligand for the TNF receptor family member TACI and shares some mechanistic similarity with immunosuppressive drug actions (cyclosporin A).

Other names
CAMLGCAMLGET2calcium-modulating cyclophilin ligand
02

Mechanism of action

Drugs (e.g., cyclosporin A) binding cyclophilins can modulate this signaling pathway by inhibiting the downstream activation of calcineurin (key T-cell activation step)

03

Biological functions

Calcium signalingSignal transductionT cell activationSurvival of peripheral follicular B cells
04

Disease associations

Cancer (regulation of calcium signaling and matrix metalloproteinase activities in melanoma)Congenital disorder of glycosylation (Type IIZ, Type IN)Potential roles in immune regulation and response to pathogens
05

Safety considerations

Modulation of calcium signaling may affect immune function (e.g., T-cell and B-cell activity)Specific safety issues in drug targeting not established
06

Interacting drugs

Cyclosporin A

Beyond the preview

Go deeper on Calcium modulating ligand (CAMLG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium modulating ligand (CAMLG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call